Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis

BackgroundNon-vitamin K antagonist oral anticoagulants (NOACs) showed a benefit-risk profile superior to that of warfarin in atrial fibrillation (AF) patients with mild to moderate chronic kidney disease. However, the effectiveness and safety of NOACs in AF patients with end-stage renal disease (ESR...

Full description

Bibliographic Details
Main Authors:	Wenhao Li, Yanxia Zhou, Siqi Chen, Dewang Zeng, Haidong Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	non-vitamin K antagonist oral anticoagulants warfarin atrial fibrillation dialysis meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.1005742/full

Similar Items

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
by: Susin Park, et al.
Published: (2022-01-01)

Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non‐Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population‐Based Cohort Study
by: Jin‐Yi Hsu, et al.
Published: (2021-03-01)

Effect of edoxaban compared with other oral anticoagulants for stroke prevention in patients with atrial fibrillation: A meta-analysis
by: Bailin Zhang, et al.
Published: (2023-11-01)

Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study
by: Tsuyoshi Shiga, MD, et al.
Published: (2015-12-01)

Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Mu-Mei Hu, et al.
Published: (2017-04-01)

Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis
by: Xinxing Gao, et al.
Published: (2022-05-01)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta‐Analysis
by: Yuqing Deng, et al.
Published: (2019-07-01)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01)

ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
by: Amer Rauf, et al.
Published: (2020-12-01)

Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?
by: Xuyang Liu, et al.
Published: (2022-05-01)

Non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with heart failure and preserved, mildly reduced, and reduced ejection fraction: A systemic review and meta-analysis
by: Kaisaier Wulamiding, et al.
Published: (2022-07-01)

Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey
by: Emre Ozdemir, et al.
Published: (2020-01-01)

The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
by: Sohil Elfar, et al.
Published: (2024-01-01)

Anticoagulant drugs for patients with atrial fibrillation on dialysis: a systematic analysis and network meta-analysis
by: Xian-Feng Shen, et al.
Published: (2023-12-01)

The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation
by: Si-qi Lyu, et al.
Published: (2024-01-01)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
by: Krishna N. Pundi, et al.
Published: (2021-12-01)

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants
by: Jo-Nan Liao, et al.
Published: (2022-07-01)

Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword
by: Francesco Vetta, et al.
Published: (2017-07-01)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
by: Joseph M. Harburger, et al.
Published: (2012-05-01)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
by: Antonio de Padua Mansur, et al.
Published: (2012-01-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study
by: Mette Søgaard, et al.
Published: (2019-06-01)

Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer
by: Anne Gulbech Ording, et al.
Published: (2022-01-01)

Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis
by: Stefan Reers, et al.
Published: (2018-10-01)

Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes
by: Iris Parrini, et al.
Published: (2022-09-01)

Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation – real-life data from a survey in Eastern Switzerland
by: Micha T. Maeder, et al.
Published: (2017-10-01)

Non-valvular Atrial Fibrillation in CKD: Role of Vitamin K Antagonists and Direct Oral Anticoagulants. A Narrative Review
by: Aleix Cases, et al.
Published: (2021-09-01)

Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials
by: Kang-Ling Wang, et al.
Published: (2017-08-01)

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019-01-01)

Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01)

Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01)

Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
by: Chun‐Li Wang, et al.
Published: (2018-08-01)

Anticoagulation in Patients with End-Stage Renal Disease and Non-Valvular Atrial Fibrillation – Review Article
by: Mahmoud Khalifa, et al.
Published: (2021-05-01)

Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?
by: Dong Lin, et al.
Published: (2021-11-01)

Non-vitamin K antagonist oral anticoagulants for heart diseases
by: T B Kondratieva, et al.
Published: (2017-09-01)

Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
by: Turagam MK, et al.
Published: (2015-09-01)

Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation
by: Nemin Chen, et al.
Published: (2018-11-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)

Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)
by: Benjamin A. Steinberg, et al.
Published: (2018-02-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)